1-(2-naphthalenyl)-3-[(phenylmethyl)-propan-2-ylamino]-1-propanone has been researched along with Autosomal Dominant Striatonigral Degeneration in 1 studies
ZM39923: structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lai, TS | 1 |
| Liu, Y | 1 |
| Tucker, T | 1 |
| Daniel, KR | 1 |
| Sane, DC | 1 |
| Toone, E | 1 |
| Burke, JR | 1 |
| Strittmatter, WJ | 1 |
| Greenberg, CS | 1 |
1 other study available for 1-(2-naphthalenyl)-3-[(phenylmethyl)-propan-2-ylamino]-1-propanone and Autosomal Dominant Striatonigral Degeneration
| Article | Year |
|---|---|
Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries.
Topics: Animals; Calcium; Combinatorial Chemistry Techniques; Disease Models, Animal; Drosophila melanogaste | 2008 |